Home › Trial NCT01260779
Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors
- Trial IDNCT01260779
- StatusUnknown
- PhaseN/A
- Study typeExpanded_Access
- SponsorProvectus Biopharmaceuticals, Inc.
- Enrollment—
- Start date—
- ConditionsCutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory · Approved Alternative Therapy
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.